NEW YORK, July 1 (GenomeWeb News) - Ciphergen Biosystems expects a significant drop in revenues for the second quarter and plans to cut costs in its instrumentation division, the company said yesterday.

 

Ciphergen estimates revenues of $10-11 million for the quarter ending yesterday, down from $14.3 million during the same period last year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.